Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Enveric Biosciences Inc (ENVB) vs Futu Holdings Ltd (FUTU) Price & Performance

Enveric Biosciences IncTrade
Futu Holdings LtdTrade

Price performance (Past 24H)

Key statistics

Enveric Biosciences Inc vs Futu Holdings Ltd — how do they compare? Enveric Biosciences Inc trades at $1.58 (market cap $6.20M), while Futu Holdings Ltd trades at $105.39 (market cap $14.74B). The key difference: Futu Holdings Ltd is far larger — about 2377.4× Enveric Biosciences Inc's market cap, and Futu Holdings Ltd pays a 2.47% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals.

ENVBFUTU
Market Cap
$6.20M$14.74B
Sector
HealthFinancials
52-Week High
$17.40$199.04
52-Week Low
$1.27$89.76
Enterprise Value
$1.30M$14.59B
Dividend Yield
2.47%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Enveric Biosciences Inc

ENVB trades at $1.56, up 1.3% on the day, with a bullish technical signal from moving averages and strong analyst support (75% buy ratings). The company reported four consecutive quarterly earnings beats in 2025, including a positive EPS of $0.85 in Q4, while recent news highlights progress in preclinical studies for its non-hallucinogenic psychiatric drug candidate EB-003.

Despite operational losses and negative ROE/ROA, ENVB's consistent earnings surprises and advancing pipeline present speculative growth potential. Key risks include cash burn, clinical trial outcomes, and regulatory hurdles, requiring careful risk assessment by investors.

Futu Holdings Ltd

Futu Holdings Limited (FUTU) trades at $108.70, showing modest daily movement with a slight decline of 0.29%. The stock exhibits a bullish technical trend, supported by moving averages, while recent earnings have been mixed with two misses and one beat against expectations. Strong revenue growth and profitability margins highlight solid fundamental performance, though the company faces significant legal and regulatory scrutiny.

The outlook for FUTU is cautiously optimistic, driven by robust financial health and analyst support, but overshadowed by ongoing securities class action lawsuits alleging regulatory compliance failures. Key risks include legal liabilities and market sentiment pressure, while opportunities lie in sustained earnings growth and favorable valuation metrics.

Returns comparison

Trailing returns across standard periods

About Enveric Biosciences Inc

Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.

Read more on ENVB

About Futu Holdings Ltd

Futu Holdings Ltd is an online broker providing one-stop online investing services. The company provides its services through its digital platform Futu NiuNiu, which includes market data, trading service, and news feed of Hong Kong, Mainland China, Singapore, and United States equity markets. It generates its revenue in the form of brokerage commission and handling charge services.

Read more on FUTU